 |
PDBsum entry 4rfc
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
A class of 4-Sulfamoylphenyl-ω-Aminoalkyl ethers with effective carbonic anhydrase inhibitory action and antiglaucoma effects.
|
 |
|
Authors
|
 |
M.Bozdag,
M.Pinard,
F.Carta,
E.Masini,
A.Scozzafava,
R.Mckenna,
C.T.Supuran.
|
 |
|
Ref.
|
 |
J Med Chem, 2014,
57,
9673-9686.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
We report a series of 4-sulfamoylphenyl-ω-aminoalkyl ethers as carbonic
anhydrase (CA, EC 4.2.1.1) inhibitors. The structure-activity relationship was
drawn for the inhibition of four physiologically relevant isoforms: hCA I, II,
IX, and XII. Many of these compounds were highly effective, low nanomolar
inhibitors of all CA isoforms, whereas several isoform-selective were also
identified. X-ray crystal structures of two new sulfonamides bound to the
physiologically dominant CA II isoform showed the tails of these derivatives
bound within the hydrophobic half of the enzyme active site through van der
Waals contacts with Val135, Leu198, Leu204, Trp209, Pro201, and Pro202 amino
acids. One of the highly water-soluble compound (as trifluoroacetate salt)
showed effective IOP lowering properties in an animal model of glaucoma. Several
fluorescent sulfonamides incorporating either the fluorescein-thiourea (7a-c) or
tetramethylrhodamine-thiourea (9a,b) moieties were also obtained and showed
interesting CA inhibitory properties for the tumor-associated isoforms CA IX and
XII.
|
 |
|
|
|
|
 |